In a recent case report published in Frontiers in Immunology, scientists in Canada described how an experimental treatment using a naturally derived substance called ibogaine appeared to improve ...

The Breakthrough Prizes have been awarded annually since 2013 to recognize accomplishments in fundamental physics, ...

Although EBV is treatable, it can trigger an array of diseases including autoimmune diseases. One major risk factor of multiple sclerosis (MS) includes EBV infection. MS is a chronic inflammatory ...

The findings reinforce the potential of BRIUMVI in improving patient outcomes for those seeking an alternative to their previous anti-CD20 therapy. Furthermore, the article in CNS DRUGS offers an ...

Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on ...

A new artificial intelligence (AI) tool called MindGlide was found to accurately calculate MS-related brain damage using a ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

TG Therapeutics (TGTX) announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis ...